GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » PS Ratio

Synergy Pharmaceuticals (FRA:S90) PS Ratio : 0.00 (As of Apr. 30, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Synergy Pharmaceuticals's share price is €0.00. Synergy Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2018 was €0.14. Hence, Synergy Pharmaceuticals's PS Ratio for today is 0.00.

Good Sign:

Synergy Pharmaceuticals Inc stock PS Ratio (=0.06) is close to 3-year low of 0.06

The historical rank and industry rank for Synergy Pharmaceuticals's PS Ratio or its related term are showing as below:

FRA:S90' s PS Ratio Range Over the Past 10 Years
Min: 0.06   Med: 15.14   Max: 474
Current: 0.06

During the past 12 years, Synergy Pharmaceuticals's highest PS Ratio was 474.00. The lowest was 0.06. And the median was 15.14.

FRA:S90's PS Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.18 vs FRA:S90: 0.06

Synergy Pharmaceuticals's Revenue per Sharefor the three months ended in Sep. 2018 was €0.04. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2018 was €0.14.

During the past 12 months, the average Revenue per Share Growth Rate of Synergy Pharmaceuticals was 431.30% per year.

Back to Basics: PS Ratio


Synergy Pharmaceuticals PS Ratio Historical Data

The historical data trend for Synergy Pharmaceuticals's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Pharmaceuticals PS Ratio Chart

Synergy Pharmaceuticals Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 30.97

Synergy Pharmaceuticals Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.94 30.97 17.10 11.84 10.00

Competitive Comparison of Synergy Pharmaceuticals's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Synergy Pharmaceuticals's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synergy Pharmaceuticals's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synergy Pharmaceuticals's PS Ratio distribution charts can be found below:

* The bar in red indicates where Synergy Pharmaceuticals's PS Ratio falls into.



Synergy Pharmaceuticals PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Synergy Pharmaceuticals's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.00/0.142
=0.00

Synergy Pharmaceuticals's Share Price of today is €0.00.
Synergy Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.14.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Synergy Pharmaceuticals  (FRA:S90) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Synergy Pharmaceuticals PS Ratio Related Terms

Thank you for viewing the detailed overview of Synergy Pharmaceuticals's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Synergy Pharmaceuticals (FRA:S90) Business Description

Traded in Other Exchanges
N/A
Address
420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170
Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines